ANTAGONIST OF THE BTLA/HVEM INTERACTION FOR USE IN THERAPY
摘要
Antagonist of the BTLA/HVEM interaction for use in therapy The present invention relates to an antagonist of the BTLA/HVEM interaction for use in therapy, wherein said antagonist increases the proliferation of Vγ9Vδ2 T cells.
申请公布号
EP2997043(A1)
申请公布日期
2016.03.23
申请号
EP20140725682
申请日期
2014.05.16
申请人
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE);INSTITUT JEAN PAOLI & IRÈNE CALMETTES;UNIVERSITÉ D'AIX-MARSEILLE;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS
